Your session is about to expire
← Back to Search
IMCY-0098 for Type 1 Diabetes (IMPACT Trial)
IMPACT Trial Summary
This trial is studying a new experimental drug to see if it can stop the body's immune system from attacking and destroying the insulin-producing cells in people with type 1 diabetes.
IMPACT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIMPACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IMPACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am being treated with insulin as per my local healthcare guidelines.I am currently experiencing a serious infection that requires IV antibiotics or hospitalization.I am between 18 and 45 years old.I have been diagnosed with LADA.You have or had HIV, Hepatitis B, or Hepatitis C infection.I do not have any uncontrolled diseases or abnormal lab results that could affect the study.I was diagnosed with Type 1 Diabetes less than 9 weeks ago.I have not taken diabetes medication other than insulin in the last week.I do not have a blood condition that affects my HbA1c levels.My blood tests show I have low white blood cells, neutrophils, lymphocytes, or platelets.My kidney function is impaired, shown by high creatinine or low eGFR.(For people in the United States only) Your HbA1c levels should be less than or equal to 9.5% before you can join the study.My liver tests are not more than 3 times the normal limit, and I don't have liver disease.Your blood pressure is consistently high, with the top number (systolic) above 129 or the bottom number (diastolic) above 89.Your C-peptide levels must be at least 200 pmol/L when tested.I have symptoms of COVID or tested positive for COVID recently.I have diabetes-related autoantibodies like GAD65, IA-2, or ZnT8.You have had a bad reaction to any part of the drug before.I am HLA DR4 positive for the main study or HLA DR3 positive for the substudy.I am on long-term steroids or other drugs that suppress my immune system.I have not received any live vaccines in the last 3 months.I am a man who can father children and will use contraception or practice abstinence for 90 days after treatment.I have a history of cancer, except for basal cell skin cancer that was removed.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many locales are presently hosting this clinical experiment?
"The four clinical trial sites participating in this research are the University of Chicago, Barbara Davis Center, the Joslin Diabetes Center and a further quartet of medical centres."
Are there any openings for participants in this current clinical trial?
"Affirmative. As per information found on clinicaltrials.gov, this medical experiment is presently recruiting patients and was initially posted in late December 2020, with the last update occurring in September 2022. There are 108 participants that need to be recruited from 4 different sites."
What are the eligibility criteria for participation in this investigation?
"To become a part of this medical investigation, individuals must have diabetes and some form of autoimmune disorder while also being between 18-44 years old. The total number of participants will be around 108 people."
Has the FDA granted authorization for IMCY-0098 450 μg?
"IMCY-0098 450 μg has been given a rating of 2 on our scale, due to the findings from Phase 2 trials that indicate its safety but lack conclusive evidence for efficacy."
Does this medical trial accept participants younger than twenty years old?
"This research project requires that individuals be aged between 18 to 44 for enrollment. In contrast, there are 217 studies available for minors and 916 trials open to seniors."
How many individuals are enrolled in the research project?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial commenced enrollment as of December 29th 2020 and is currently recruiting participants. As such, 108 patients need to be recruited from 4 distinct sites."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger